Celecoxib prevents juxta-articular osteopenia and growth plate destruction adjacent to inflamed joints in rats with collagen-induced arthritis

Modern Rheumatology

Volumn 17, Issue 2, 2007, Pages 115-122

  Tsuboi, Hideki ^a   Nampei, Akihide ^a   Matsui, Yoshito ^a   Hashimoto, Jun ^a   Kawai, Shinichi ^b   Ochi, Takahiro ^c   Yoshikawa, Hideki ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

Celecoxib; Growth plate destruction; Juvenile idiopathic arthritis; Juxta articular osteopenia; Rheumatoid arthritis

Indexed keywords

CELECOXIB; COLLAGEN; DEXAMETHASONE; INDOMETACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE RADIOGRAPHY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BONE DENSITY; BONE DESTRUCTION; BONE MINERAL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; GROWTH PLATE; HISTOPATHOLOGY; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; PRIMARY PREVENTION; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, EXPERIMENTAL; BONE DENSITY; BONE DISEASES, METABOLIC; DEXAMETHASONE; GROWTH PLATE; HINDLIMB; INDOMETHACIN; MALE; PYRAZOLES; RATS; RATS, INBRED LEW; SULFONAMIDES;

EID: 34247201515     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-007-0552-4     Document Type: Article

References (42)

1. EM Gravallese Y Harada JT Wang AH Gorn TS Thornhill SR Goldring 1998 Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis Am J Pathol 152 943-51 9546355 1:STN:280:DyaK1c3gs1Cgsw%3D%3D
2. PP Tak B Bresnihan 2000 The pathogenesis and prevention of joint damage in rheumatoid arthritis: Advances from synovial biopsy and tissue analysis Arthritis Rheum 43 2619-33 11145019 10.1002/ 1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V 1:STN:280:DC%2BD3M%2FnvFynsQ%3D%3D
3. SM Krane 1993 Mechanism of tissue destruction in rheumatoid arthritis. Arthritis and allied conditions 12th ed Lea & Febiger Malvern, PA
4. S Simon J Whiffen F Shapiro 1981 Leg-length discrepancies in monoarticular and pauciarticular juvenile rheumatoid arthritis J Bone Joint Surg (A) 63 2 209-15 1:STN:280:Bi6C3MjktFI%3D
5. EA Meade WL Smith DL DeWitt 1993 Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs J Biol Chem 268 9 6610-4 8454631 1:CAS:528:DyaK3sXkt1Sis7w%3D
6. GP O'Neill JA Mancini S Kargman J Yergey MY Kwan JP Falgueyret 1994 Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus: Inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid Mol Pharmacol 45 2 245-54 8114674
7. S Bombardieri P Cattani G Ciabattoni O Di Munno G Pasero C Patrono 1981 The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs Br J Pharmacol 73 4 893-901 6895043 1:CAS:528:DyaL38Xks1w%3D
8. P Davies PJ Bailey MM Goldenberg AW Ford-Hutchinson 1984 The role of arachidonic acid oxygenation products in pain and inflammation Annu Rev Immunol 2 335-57 6100476 10.1146/annurev.iy.02.040184.002003 1:CAS:528:DyaL2cXkslShtr8%3D
9. GP O'Neill AW Ford-Hutchinson 1993 Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues FEBS Lett 330 2 156-60 8365485 10.1016/0014-5793(93)80263-T
10. LJ Crofford 1999 COX-2 in synovial tissues Osteoarthritis Cartilage 7 4 406-8 10419782 10.1053/joca.1999.0226 1:STN:280:DyaK1MzltVyjug%3D%3D
11. Y Okada JA Lorenzo AM Freeman M Tomita SG Morham LG Raisz 2000 Prostaglandin G/H synthase-2 is required for maximal formation of osteoclast-like cells in culture J Clin Invest 105 6 823-32 10727451 1:CAS:528:DC%2BD3cXhvFehsbY%3D
12. Y Okada C Pilbeam L Raisz Y Tanaka 2003 Role of cyclooxygenase-2 in bone resorption J UOEH 25 2 185-95 12813861 1:CAS:528:DC%2BD3sXms1ynsbY%3D
13. H Yasuda N Shima N Nakagawa K Yamaguchi M Kinosaki S Mochizuki 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/ osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL Proc Natl Acad Sci USA 95 7 3597-602 9520411 10.1073/pnas.95.7.3597 1:CAS:528:DyaK1cXitlKjsLY%3D
14. NT Ilowite 2002 Current treatment of juvenile rheumatoid arthritis Pediatrics 109 1 109-15 11773549 10.1542/peds.109.1.109
15. H Kawaguchi D Chikazu K Nakamura M Kumegawa Y Hakeda 2000 Direct and indirect actions of fibroblast growth factor 2 on osteoclastic bone resorption in cultures J Bone Miner Res 15 3 466-73 10750561 10.1359/ jbmr.2000.15.3.466 1:CAS:528:DC%2BD3cXitFaktrs%3D
16. K Igarashi JT Woo PH Stern 2002 Effects of a selective cyclooxygenase-2 inhibitor, celecoxib, on bone resorption and osteoclastogenesis in vitro Biochem Pharmacol 63 3 523-32 11853703 10.1016/S0006-2952(01)00861-9 1:CAS:528:DC%2BD38Xhtleqtbs%3D
17. M Katagiri T Ogasawara K Hoshi D Chikazu A Kimoto M Noguchi 2006 Suppression of adjuvant-induced arthritic bone destruction by cyclooxygenase-2 selective agents with and without inhibitory potency against carbonic anhydrase II J Bone Miner Res 21 2 219-27 16418777 10.1359/JBMR.051025 1:CAS:528:DC%2BD28Xhs1Kmu74%3D
18. SC Mastbergen FP Lafeber JW Bijlsma 2002 Selective COX-2 inhibition prevents proinflammatory cytokine-induced cartilage damage Rheumatology (Oxford) 41 7 801-8 10.1093/rheumatology/41.7.801 1:CAS:528:DC%2BD38Xmt1Ohs7g%3D
19. E Bogoch N Gschwend B Bogoch B Rahn S Perren 1988 Juxta-articular bone loss in experimental inflammatory arthritis J Orthop Res 6 5 648-56 3404321 10.1002/jor.1100060505 1:STN:280:BieA3c%2FjtFY%3D
20. K Takahi J Hashimoto K Hayashida K Shi H Takano H Tsuboi 2002 Early closure of growth plate causes poor growth of long bones in collagen-induced arthritis rats J Musculoskelet Neuronal Interact 2 4 344-51 15758426 1:STN:280:DC%2BD2M7islKitw%3D%3D
21. T Tomita E Takeuchi N Tomita R Morishita M Kaneko K Yamamoto 1999 Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor β decoy oligodeoxynucleotides as a gene therapy Arthritis Rheum 42 12 2532-42 10615998 10.1002/ 1529-0131(199912)42:12<2532::AID-ANR5>3.0.CO;2-2 1:CAS:528:DC%2BD3cXjslagtA%3D%3D
22. TR Nagy CW Prince J Li 2001 Validation of peripheral dual-energy X-ray absorptiometry for the measurement of bone mineral in intact and excised long bones of rats J Bone Miner Res 16 9 1682-7 11547838 10.1359/ jbmr.2001.16.9.1682 1:STN:280:DC%2BD3Mvpslelsw%3D%3D
23. S Nishida A Yamaguchi T Tanizawa N Endo T Mashiba Y Uchiyama 1994 Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow Bone 15 6 717-23 7873302 10.1016/8756-3282(94)90322-0 1:CAS:528:DyaK2MXitFSkt7Y%3D
24. AM Parfitt MK Drezner FH Glorieux JA Kanis H Malluche PJ Meunier 1987 Bone histomorphometry: Standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee J Bone Miner Res 2 6 595-610 3455637 1:STN:280:BieA3sfjsFc%3D
25. T Hanyu T Chotanaphuti K Arai T Tanaka HE Takahashi 1999 Histomorphometric assessment of bone changes in rats with type II collagen-induced arthritis Bone 24 5 485-90 10321908 10.1016/ S8756-3282(99)00006-X 1:STN:280:DyaK1M3ltlyhtw%3D%3D
26. EM Gravallese C Manning A Tsay A Naito C Pan E Amento 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 2 250-8 10693863 10.1002/ 1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P 1:STN:280:DC%2BD3c7lsFGgsg%3D%3D
27. H Takayanagi H Iizuka T Juji T Nakagawa A Yamamoto T Miyazaki 2000 Involvement of receptor activator of nuclear factor kappaB ligand/ osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 2 259-69 10693864 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W 1:CAS:528:DC%2BD3cXhs1aqtLw%3D
28. Y Shigeyama T Pap P Kunzler BR Simmen RE Gay S Gay 2000 Expression of osteoclast differentiation factor in rheumatoid arthritis Arthritis Rheum 43 11 2523-30 11083276 10.1002/ 1529-0131(200011)43:11<2523::AID-ANR20>3.0.CO;2-Z 1:STN:280:DC%2BD3M%2FktFCjuw%3D%3D
29. T Hirayama L Danks A Sabokbar NA Athanasou 2002 Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis Rheumatology (Oxford) 41 11 1232-39 10.1093/rheumatology/41.11.1232 1:CAS:528:DC%2BD38XosFOhu7o%3D
30. N Udagawa S Kotake N Kamatani N Takahashi T Suda 2002 The molecular mechanism of osteoclastogenesis in rheumatoid arthritis Arthritis Res 4 5 281-9 12223101 10.1186/ar431 1:CAS:528:DC%2BD38XmvFCit74%3D
31. AL Hsu TT Ching DS Wang X Song VM Rangnekar CS Chen 2000 The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2 J Biol Chem 275 15 11397-403 10753955 10.1074/jbc.275.15.11397 1:CAS:528:DC%2BD3cXislShu70%3D
32. S Grosch I Tegeder E Niederberger L Brautigam G Geisslinger 2001 COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib FASEB J 15 14 2742-4 11606477 1:STN:280:DC%2BD3MnotVeksg%3D%3D
33. KM Leahy RL Ornberg Y Wang BS Zweifel AT Koki JL Masferrer 2002 Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo Cancer Res 62 3 625-31 11830509 1:CAS:528:DC%2BD38Xht1KrtLs%3D
34. N Kusunoki R Yamazaki S Kawai 2002 Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors Arthritis Rheum 46 12 3159-67 12483719 10.1002/art.10692 1:CAS:528:DC%2BD3sXjslGisw%3D%3D
35. N Kusunoki T Ito N Sakurai T Suguro H Handa S Kawai 2005 A novel celecoxib derivative potently induces apoptosis of human synovial fibroblasts J Pharmacol Exp Ther 314 2 796-803 15870389 10.1124/ jpet.105.086116 1:CAS:528:DC%2BD2MXntVSisLc%3D
36. S Kawai K Nagai S Nishida K Sakyo E Murai Y Mizushima 1997 Low-dose pulse methotrexate inhibits articular destruction of adjuvant arthritis in rats J Pharm Pharmacol 49 2 213-5 9055198 1:CAS:528:DyaK2sXitFemtbo%3D
37. Y Segawa M Yamaura S Aota T Omata N Tuzuike Y Itokazu 1997 Methotrexate maintains bone mass by preventing both a decrease in bone formation and an increase in bone resorption in adjuvant-induced arthritic rats Bone 20 5 457-64 9145243 10.1016/S8756-3282(97)00023-9 1:CAS:528:DyaK2sXjsV2iu7w%3D
38. T Takagi PW Tsao R Totsuka T Suzuki T Murata I Takata 1998 Dexamethasone prevents the decrease of bone mineral density in type II collagen-induced rat arthritis model Jpn J Pharmacol 78 2 225-8 9829626 10.1254/jjp.78.225 1:CAS:528:DyaK1cXmvFyqsLw%3D
39. M Abdelrahim S Safe 2005 Cyclooxygenase-2 inhibitors decrease vascular endothelial growth factor expression in colon cancer cells by enhanced degradation of Sp1 and Sp4 proteins Mol Pharmacol 68 2 317-29 15883203 1:CAS:528:DC%2BD2MXntVSnsr0%3D
40. C Sanchez MM Mateus MP Defresne JM Crielaard JY Reginster YER Henrotin 2002 Metabolism of human articular chondrocytes cultured in alginate beads. Longterm effects of interleukin 1beta and nonsteroidal anti-inflammatory drugs J Rheumatol 29 4 772-82 11950021 1:CAS:528:DC%2BD38XjtFGltLo%3D
41. D Chrysis EM Ritzen L Savendahl 2003 Growth retardation induced by dexamethasone is associated with increased apoptosis of the growth plate chondrocytes J Endocrinol 176 3 331-7 12630918 10.1677/joe.0.1760331 1:CAS:528:DC%2BD3sXis1amtrg%3D
42. JE McDonagh 2001 Osteoporosis in juvenile idiopathic arthritis (Review) Curr Opin Rheumatol 13 5 399-404 11604595 10.1097/ 00002281-200109000-00010 1:STN:280:DC%2BD3Mrls1ynsw%3D%3D